Bio-Techne’s Exosome Diagnostics Lab Receives Accreditation From College of American Pathologists (CAP)
- Tuesday, December 17, 2019, 7:04
- Finance
- Add a comment
MINNEAPOLIS, Dec. 17, 2019 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that the Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to its Exosome Diagnostics (ExosomeDx) laboratory based on results of a recent on-site…
About the Author
adminasapcorp has written 42190 stories on this site.